Cryoport, Inc. (CYRX): חוב לטווח קצר של החברה

Cryoport, Inc. (CYRX) provides critical transportation of biomaterials for genetic medicine, combining cryogenic packaging with digital control. However, the slow market entry of new drugs and the costs of specialized storage create certain challenges, while the specific short-term debt metric stands at 0.18. The market trend of the share price confirms the influence of these fundamental factors on the company's price action.

For Cryoport, Inc., a leader in cryogenic logistics, this indicator determines the volume of obligations with a maturity horizon of up to twelve months. The metric measures the current liquidity burden by recording the total amount of short-term loans and credits. By analyzing the organization's short-term debt, an investor sees the value of 0.18. This allows for an assessment of the company's ability to finance its costly IT monitoring infrastructure. The stability of this figure confirms the business's financial resilience within the gene therapy segment.